HPV Vaccine

Human Papillomavirus vaccine protects against HPV strains causing cervical cancer, genital warts, and other anogenital cancers. India's CERVAVAC (quadrivalent) is now part of the national programme for girls.

The HPV Vaccine is recommended for 9–14 years (2-dose schedule); 15–26 years (3-dose schedule). It falls under the Adolescent vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The HPV Vaccine has an efficacy of 97–99%. This means it provides significant protection against Cervical Cancer and Genital Warts. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Pain; swelling at injection site; headache; dizziness. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The HPV Vaccine should be avoided by: Pregnancy; severe allergy to yeast or any vaccine component. Always inform your healthcare provider of your full medical history before vaccination.

The HPV Vaccine typically costs ₹2,000 – ₹4,000 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.